Real-time · AI · Cross-signal

Norgine just made a move. Here's exactly what to do next.

Who to reach, what to say, and why now — on Norgine, plus every M&A move, funding round, and exec hire that follows. Verified, ICP-ranked contacts on demand (email + mobile).

Used by professionals at BlackRock, Oracle, Kleiner Perkins, HubSpot, and other leading firms — built on 10 years of proprietary signal data.

Choose your plan Request a demo

Everyone else gives you a piece

✕Crunchbase & PitchBook list the company — No person, no timing, no opener.

✕ZoomInfo & Apollo sell you a contact — No trigger, no reason to reach out now.

✕LinkedIn Sales Navigator shows you people — No real-time signal, no opener.

✕Clay enriches lists you built — No live signal of its own, no who or when.

✕ChatGPT & gen-AI tools answer on a delay — No live data, no verified contact.

Who to contactWhat to sayWhen to reach outWhy now

Only Fundz delivers all four.

Norgine acquires Theravia for rare disease expansion

PRIVATEAug 14, 2025•10 months ago

Acquiring Company

Norgine

Acquired Company

Theravia

Amsterdam

ParisBiotechnologyBiotechnologyHealth CareMedicalPharmaceutical

Description

Norgine has successfully completed the acquisition of Theravia, enhancing its portfolio in rare disease medicines. This strategic move will help Norgine deliver life-changing therapies to patients in high unmet medical needs. The integration process will align both companies' operations and expertise. Theravia will now operate as a wholly owned subsidiary of Norgine.

Company Information

Company

Norgine

Location

Amsterdam, North Holland, Netherlands

About

Norgine is a European specialty pharmaceutical company that has strived to deliver innovative medicines to patients for over a century. The Company's extensive European experience, fully integrated infrastructure, and exceptional partnership approach allow it to quickly apply creative solutions to bring patients life-changing medicines that they may not otherwise be able to access. Norgine is proud to have helped 24 million patients around the world in 2021 and generated €505 million in net product sales, representing growth of 10% over 2020. Norgine has a direct presence in 16 European countries, as well as Australia and New Zealand, and employs over 1,500 people. Norgine and the sail logo are trademarks of the Norgine group of companies.

Related People

Choose your plan to reveal verified contacts

Predictive Intelligence

Strategic

ML-powered predictions for Norgine's next move

Learn about Strategic plan

M&A Insights

Based on deal data

Integration timeline

70% of M&A integrations take 12-24 months to complete

Tech stack consolidation

83% of merged companies consolidate technology vendors within first year

Post-acquisition investment

Companies increase IT spending by 23% on average after acquisitions

Success factor

M&A deals with strong technology integration plans are 2.5x more likely to succeed